Charles Crawley

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

Peter Connick, Madhan Kolappan, Charles Crawley et al. · The Lancet Neurology · 2012 · 606 citations · Full text

Life Sciences, Neurology, Neuroscience +15

Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis

Thomas McKerrell, Naomi Park, Thaidy Moreno-Rodriguez et al. · Cell Reports · 2015 · 529 citations · Full text

Life Sciences, Genetics, Hematology +17

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers

Mark Cobbold, Naeem Khan, Batoul Pourgheysari et al. · The Journal of Experimental Medicine · 2005 · 477 citations · Full text

Life Sciences, Hematology, Immunology +15

Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML)

Oliver Goodyear, Mike Dennis, Nadira Jilani et al. · Blood · 2012 · 398 citations

Life Sciences, Immunology, Oncology +17

Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Aloïs Gratwohl, Ronald Brand, Jane F. Apperley et al. · PubMed · 2006 · 260 citations

Medicine, Hematology, Oncology +13